Interested in Chimeric Antigen Receptor Therapy (CAR-T)? Stanford offers CAR-T Therapy for Diffuse Large B-Cell Lymphoma, Acute Lymphoblastic Leukemia, Multiple Myeloma, and Follicular Lymphoma patients. Fill out the required fields and we will follow up in 1-2 business days.
CAR-T Therapy of DLBCL patients at Stanford require:
- Review of all PETCT images. Scans performed outside Stanford will need to be provided as CD files for review at the time
- Lymph node biopsy specimens will require Stanford pathology review. Blocks and slides will be requested for pathology review